bg
N

Nkarta (NKTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Nkarta (NKTX)

Nkarta, Inc. is a biopharmaceutical company that is focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer. Its modular NK cell engineering platform allow... Read more

  • USD7.87
  • USD8.33
  • USD7.35
  • USD16.24
  • -22.00%
  • --
  • 820.34k
  • 943.77k
  • 484M
  • 1.28
  • 52.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.